ClinicalTrials.gg
CompletedNCT04813887Updated Sep 9, 2021

Skin Diseases and Pregnancy: Which Heathcare Professionals ?

An observational study in Skin Abnormalities and Pregnancy, sponsored by Centre Hospitalier Departemental Vendee. Completed at 1 site in France. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-09-09.

Sponsored by Centre Hospitalier Departemental Vendee · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
317
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Pregnancy-induced physiological dermatological changes are common. In 2016, they represented between 23% (acne) and 75% (pigmentary changes) of pregnancies in France. Some dermatological changes require medical advice to identify a possible pathological rash.

These pathological rashes can be dangerous for the mother or the fetus.

The aim of this study is to assess the prevalence of skin diseases during pregnancy and to evaluate the care pathway in a healthcare sector (Vendee) for these pregnant women?

Read the detailed description

Pregnancy-induced physiological dermatological changes are common. In 2016, they represented between 23% (acne) and 75% (pigmentary changes) of pregnancies in France. Some dermatological changes require medical advice to identify a possible pathological rash.

These pathological rashes can be dangerous for the mother or the fetus. It is therefore essential to recognize them for a quick specialized treatment. They include: intrahepatic cholestasis of pregnancy, pemphigoid gestationis, polymorphic eruption during pregnancy, atopic eczema, generalized pustular psoriasis in pregnancy.

In view of the demography of dermatologists in the Vendee, 18 dermatologists in 2020 in all establishments (hospitals, clinics, practices), the general practitioner is at the center of these considerations.

The aim of this study is to assess the situation of skin disease during pregnancy and to evaluate the care pathway in a healthcare sector (Vendee) for these pregnant women?

02

Conditions studied

  • Skin Abnormalities
  • Pregnancy

Browse trials for

03

In context

Skin Abnormalities

39 studies on the registry are indexed under Skin Abnormalities; 7 are open to participants now.

This study's enrollment of 317 is above the median of 140 across 11 observational studies indexed under Skin Abnormalities.

Browse Skin Abnormalities studies →

Lead sponsor

Centre Hospitalier Departemental Vendee is the lead sponsor of 83 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Prospective collection of data from a questionnaire answered by patients giving birth at the Departmental Hospital Center of Vendee during the postpartum period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any woman who gives birth at Departmental Hospital Center of Vendee

Exclusion criteria

Exclusion Criteria:

  • Patient's refusal to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
317 participants (actual)
Patient registry
No

Interventions

  • Otherquestionnaire

    Self-questionnaire on skin diseases reported during pregnancy

06

What researchers measure

Primary outcomes

  1. Identify the health care provider that pregnant women consult when experiencing a skin disease

    Type of health care provider seeing a pregnant woman for skin disease

    Time frame: after delivery during the patient's stay in the maternity (2-3 days)

07

Study locations

1 site
  • CHD Vendée
    La Roche sur Yon, 85000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04813887
Lead sponsor
Centre Hospitalier Departemental Vendee
Responsible party
Sponsor
First posted
Mar 24, 2021
Start date
Apr 7, 2021
Primary completion
Apr 7, 2021
Completion
Aug 10, 2021
Last update
Sep 9, 2021

Study contacts

Guillaume DUCARME
principal investigator · Departmental Hospital Center of Vendee

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion